(Press-News.org) Delivering a single injection of a scar-busting gene therapy to the spinal cord of rats following injury promotes the survival of nerve cells and improves hind limb function within weeks, according to a study published April 2 in The Journal of Neuroscience. The findings suggest that, with more confirming research in animals and humans, gene therapy may hold the potential to one day treat people with spinal cord injuries.
The spinal cord is the main channel through which information passes between the brain and the rest of the body. Most spinal cord injuries are caused by damage to the axons, the long extensions that brain cells use to send these messages. Once these injuries take place, scar tissue forms and prevents the damaged nerves from re-growing.
Previous animal studies show that one way to promote the growth of injured spinal nerve cells is to administer the enzyme chondroitinase ABC (ChABC), which digests scar-forming proteins, to the site of injury. However, because ChABC breaks down quickly, maintaining these beneficial effects for a long period of time requires invasive and repeated administration of the enzyme to the spinal cord. To get around this hurdle, in recent years, scientists began exploring gene therapy as a method to efficiently coax spinal cord cells to produce the enzyme.
In the current study, a group of researchers led by Elizabeth Bradbury, PhD, of King's College London used a single injection to deliver the ChABC gene therapy into the spinal cord of injured adult rats. The treatment not only led the spinal cord cells to produce and secrete ChABC in large quantities over areas spanning the injury epicenter, it helped to maintain the overall health of the damaged spinal cord and restored hind limb function in the animals within 12 weeks.
"These findings provide convincing evidence that gene therapy with chondroitinase not only encourages the sprouting of injured axons, but also imparts significant protection to nerve cells," said Mark Tuszynski, MD, PhD, who studies how nerve cells recover following injury at the University of California, San Diego, and was not involved in this study. "These are new and important findings that could lead to the development of testable therapies for spinal cord injury in people," he added.
Bradbury's team delivered the ChABC gene into the matrix of the spinal cord (the space between spinal cord cells). Twelve weeks later, the animals that received the therapy had more surviving spinal nerve cells and fibers present through and around the scar compared with animals that did not receive the treatment. ChABC gene therapy also led to the recovery of hind limb function in the animals, allowing them to navigate the rungs of a horizontal ladder.
Additional analysis revealed that ChABC gene therapy changed the way that inflammatory cells in the region respond following injury. Normally, after injury, immune cells invade the spinal cord and cause destructive and irreparable tissue damage. However, ChABC gene therapy decreased the presence of these cells and increased the presence of other immune cells called M2 macrophages that help to reduce inflammation and enhance tissue repair.
"This scar-busting therapy represents an important advance since it reveals a novel interaction between the supportive matrix and the immune cells following an injury," Bradbury said. The ability to treat large areas of the spinal cord for extended periods of time in animals "will be important for scaling up to the larger human spinal cord for future translation of this therapy to the clinic," she added.
INFORMATION:
This research was supported by the U.K. Medical Research Council, the International Spinal Research Trust, and the Henry Smith Charity.
The Journal of Neuroscience is published by the Society for Neuroscience, an organization of nearly 40,000 basic scientists and clinicians who study the brain and nervous system. Bradbury can be reached at elizabeth.bradbury@kcl.ac.uk.
More information on spinal cord injury can be found on BrainFacts.org.
Gene therapy improves limb function following spinal cord injury
Animal study points to promise of gene therapy for treating spinal cord injury
2014-04-02
ELSE PRESS RELEASES FROM THIS DATE:
Mode of action of new multiple sclerosis drug discovered
2014-04-02
This news release is available in German. Just a few short weeks ago, dimethyl fumarate was approved in Europe as a basic therapy for multiple sclerosis. Although its efficacy has been established in clinical studies, its underlying mode of action was still unknown, but scientists from Bad Nauheim's Max Planck Institute for Heart and Lung Research and the University of Lübeck have now managed to decode it. They hope that this knowledge will help them develop more effective therapeutic agents.
Multiple sclerosis (MS) is a chronic inflammatory disease of the central ...
Well-rested flies
2014-04-02
This news release is available in German. Elderly flies do not sleep well – they frequently wake up during the night and wander around restlessly. The same is true of humans. For researchers at the Max Planck Institute for Biology of Ageing in Cologne, the sleeplessness experienced by the fruit fly Drosophila is therefore a model case for human sleeping behaviour. The scientists have now discovered molecules in the flies' cells that affect how the animals sleep in old age: if insulin/IGF signalling is active, the quality of the animals' sleep is reduced and they wake ...
Penn Medicine points to new ways to prevent relapse in cocaine-addicted patients
2014-04-02
(PHILADELPHIA) – Relapse is the most painful and expensive feature of drug addiction—even after addicted individuals have been drug-free for months or years, the likelihood of sliding back into the habit remains high. The National Institute on Drug Abuse estimates that 40 to 60 percent of addicted individuals will relapse, and in some studies the rates are as high as 80 percent at six months after treatment. Though some relapse triggers can be consciously avoided, such as people, places and things related to drug use, other subconscious triggers related to the brain's reward ...
The mammography dilemma
2014-04-01
A comprehensive review of 50 year's worth of international studies assessing the benefits and harms of mammography screening suggests that the benefits of the screening are often overestimated, while harms are underestimated. And, since the relative benefits and harms of screening are related to a complex array of clinical factors and personal preferences, physicians and patients need more guidance on how best to individualize their approach to breast cancer screening.
The results of the review by researchers at Harvard Medical School's Department of Health Care Policy ...
Overuse of blood transfusions increases infection risk
2014-04-01
ANN ARBOR, Mich. — Blood transfusions are one of the most common procedures patients receive in the hospital but the more red blood cells they receive, the greater their risk of infection, says a new study led by the University of Michigan Heath System and VA Ann Arbor Healthcare System.
Researchers analyzed 21 randomized controlled trials for the study that appears in today's Journal of the American Medical Association (JAMA).
Elderly patients undergoing hip or knee surgeries were most susceptible, with a 30 percent lower risk of infection when fewer transfusions ...
Medication does not help prevent ED following radiation therapy for prostate cancer
2014-04-01
Among men undergoing radiation therapy for prostate cancer, daily use of the erectile dysfunction drug tadalafil, compared with placebo, did not prevent loss of erectile function, according to a study in the April 2 issue of JAMA.
Erectile dysfunction (ED) is a common condition resulting from many causes, including prostate cancer treatment. An estimated 40 percent of men report ED after radiation therapy, and half of all men use erectile aids following this therapy. Tadalafil is used to treat erectile dysfunction after prostate cancer treatment, but its role as a preventive ...
Outcomes of administering blood transfusions to patients with lower levels of hemoglobin
2014-04-01
Restricting red blood cell (RBC) transfusions among hospitalized patients to those with hemoglobin (the iron-containing protein in RBCs) measures below a certain level is associated with a lower risk of health care-associated infections, according to a study in the April 2 issue of JAMA.
Efforts to prevent health care-associated infection are among the priorities for the U.S. Department of Health and Human Services. The estimated annual direct medical costs of health care-associated infections to U.S. hospitals ranges from $28 billion to $45 billion, with about 1 in ...
The potential conflict of interest for leaders of AMCs serving on pharmaceutical boards
2014-04-01
About 40 percent of pharmaceutical company boards of directors examined had at least one member who held a leadership position at an academic medical center, with annual compensation for these positions averaging approximately $300,000, according to a study in the April 2 issue of JAMA.
"Financial relationships between the pharmaceutical industry and physicians have come under increased scrutiny. Less attention has been paid to relationships between industry and the leadership of academic medical centers (AMCs), who wield considerable influence over research, clinical, ...
Experts question routine mammograms in elderly
2014-04-01
Doctors should focus on life expectancy when deciding whether to order mammograms for their oldest female patients, since the harms of screening likely outweigh the benefits unless women are expected to live at least another decade, according to a review of the scientific literature by experts at UCSF and Harvard medical schools.
National guidelines recommend that doctors make individualized screening decisions for women 75 and older. But the analysis, published online Tuesday in JAMA (March 31, 2014), concluded that since this age group was not included in mammography ...
Night owls, unlike early birds, tend to be unmarried risk-takers
2014-04-01
Women who are night owls share the same high propensity for risk-taking as men, according to a recent study by a University of Chicago professor.
The research suggests that sleep patterns are linked with important character traits and behavior, said study author Dario Maestripieri, professor in Comparative Human Development. Night owls—people who tend to stay up late and wake up late in the morning—are different in many important ways from early risers, he found.
"Night owls, both males and females, are more likely to be single or in short-term romantic relationships ...
LAST 30 PRESS RELEASES:
Firms that read more perform better
Tightly tied waist cord of saree underskirt may pose cancer risk, warn doctors
10% of children in high-burden tuberculosis settings may develop the disease by age 10
Health experts push for the elimination of a ‘remarkably harmful toxin’
University of Tennessee, Lockheed Martin expand Master Research Agreement
Testing thousands of RNA enzymes helps find first ‘twister ribozyme’ in mammals
Groundbreaking study provides new evidence of when Earth was slushy
International survey of more than 1600 biomedical researchers on the perceived causes of irreproducibility of research results
Integrating data from different experimental approaches into one model is challenging – this study presents a community-based, full-scale in silico model of the rat hippocampal CA1 region that integra
SwRI awarded grant to characterize Las Moras Springs watershed
Water overuse in MATOPIBA could mean failure to meet up to 40% of local demand for crop irrigation
An extra year of education does not protect against brain aging
Researchers from Uppsala and Magdeburg obtain an ERC Synergy Grant to advance cancer immunotherapy
Deaf male mosquitoes don’t mate
Recognizing traumatic brain injury as a chronic condition fosters better care over the survivor’s lifetime
SwRI’s Dr. James Walker receives Distinguished Scientist Award from Hypervelocity Impact Society
A mother’s health problems pose a risk to her children
Ensuring a bright future for diamond electronics and sensors
The American Pediatric Society selects Dr. Maria Trent as the Recipient of the 2025 David G. Nichols Health Equity Award
The first 3D view of the formation and evolution of globular clusters
Towards a hydrogen-powered future: highly sensitive hydrogen detection system
Scanning synaptic receptors: A game-changer for understanding psychiatric disorders
High-quality nanomechanical resonators with built-in piezoelectricity
ERC Synergy Grants for 57 teams tackling major scientific challenges
Nordic research team receives €13 million to explore medieval book culture
The origin of writing in Mesopotamia is tied to designs engraved on ancient cylinder seals
Explaining science through dance
Pioneering neuroendocrinologist's century of discovery launches major scientific tribute series
Gendered bilingualism in post-colonial Korea
Structural safety monitoring of buildings with color variations
[Press-News.org] Gene therapy improves limb function following spinal cord injuryAnimal study points to promise of gene therapy for treating spinal cord injury